pharma deals

Three major deals contributed 79.7 per cent of the total deal value during September 2025

Under the terms of the agreement, 3SBio will grant Pfizer an exclusive global license to develop, manufacture and commercialise…

GlobalData reveals the pharma and healthcare industry reported 81 deals worth $9.6 billion and 85 venture capital deals worth $2…

Shilpa to undertake both development and commercial supply for mAbTree’s novel checkpoint inhibitor

Three major deals contributed 70 per cent of the total deal value during December 2024

As per Tracxn.com, funding increases 1440.84 per cent from November 2024

Lupin has been marketing the Huminsulin range of products through existing distribution and promotion agreements with Lilly, India…

The funding would be used to launch a zero-sugar range, upgrade compositions to make the brand sugar-free and diversify into…

According to GlobalData, M&A deal value declined by 2 per cent, and venture capital investments decreased by 5 per cent in…

This collaboration aims to combine local expertise with global biomanufacturing capabilities